Canakinumab Subcutaneous and Lamivudine and tenofovir
Determining the interaction of Canakinumab Subcutaneous and Lamivudine and tenofovir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: lamivudine / tenofovir
Brand name: Cimduo, Temixys
Synonyms: Lamivudine and Tenofovir Disoproxil Fumarate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Lamivudine and Tenofovir Disoproxil Fumarate
- Canakinumab Subcutaneous-Lamivudine and zidovudine
- Canakinumab Subcutaneous-Lamivudine and Zidovudine Tablets
- Canakinumab Subcutaneous-Lamivudine Oral Solution
- Canakinumab Subcutaneous-Lamivudine Tablets
- Canakinumab Subcutaneous-Lamotrigine
- Lamivudine and tenofovir-Canasa
- Lamivudine and tenofovir-Canasa Pac rectal
- Lamivudine and tenofovir-Canasa rectal
- Lamivudine and tenofovir-Cancidas
- Lamivudine and tenofovir-Candesartan
- Lamivudine and tenofovir-Candesartan and Hydrochlorothiazide